3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine

C97H120N30O4 — CID 167613436

IUPAC3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine
SMILESCCN1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.CCNc1cc(-c2cnc(N)c(Oc3cnn(CCC#N)c3)n2)cc2c1CCN(C)C2.CN1CCc2c(cc(-c3cnc(N)c(Oc4cnn(CCC#N)c4)n3)cc2NC2CC2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(CC5CC5)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C27H35N7O.C25H33N7O.C23H26N8O.C22H26N8O/c1-18-11-20(12-21-16-32(2)8-7-24(18)21)25-14-29-26(28)27(31-25)35-23-13-30-34(17-23)22-5-9-33(10-6-22)15-19-3-4-19;1-4-31-9-5-20(6-10-31)32-16-21(13-28-32)33-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18;1-30-8-5-19-16(13-30)9-15(10-20(19)28-17-3-4-17)21-12-26-22(25)23(29-21)32-18-11-27-31(14-18)7-2-6-24;1-3-25-19-10-15(9-16-13-29(2)8-5-18(16)19)20-12-26-21(24)22(28-20)31-17-11-27-30(14-17)7-4-6-23/h11-14,17,19,22H,3-10,15-16H2,1-2H3,(H2,28,29);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27);9-12,14,17,28H,2-5,7-8,13H2,1H3,(H2,25,26);9-12,14,25H,3-5,7-8,13H2,1-2H3,(H2,24,26)
InChIKeyLJSAGNWYVQOLBR-UHFFFAOYSA-N
MW1770.23 g/mol
LogP13.96
Rot. Bonds25

About 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine

3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine (PubChem CID 167613436) has the molecular formula C97H120N30O4 and a molecular weight of 1770.23 g/mol. Its IUPAC name is 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine.

Molecular Properties

Compound Name3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine
PubChem CID167613436
Molecular FormulaC97H120N30O4
Molecular Weight1770.23 g/mol
Exact Mass1769.01
IUPAC Name3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine
SMILESCCN1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.CCNc1cc(-c2cnc(N)c(Oc3cnn(CCC#N)c3)n2)cc2c1CCN(C)C2.CN1CCc2c(cc(-c3cnc(N)c(Oc4cnn(CCC#N)c4)n3)cc2NC2CC2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(CC5CC5)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C27H35N7O.C25H33N7O.C23H26N8O.C22H26N8O/c1-18-11-20(12-21-16-32(2)8-7-24(18)21)25-14-29-26(28)27(31-25)35-23-13-30-34(17-23)22-5-9-33(10-6-22)15-19-3-4-19;1-4-31-9-5-20(6-10-31)32-16-21(13-28-32)33-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18;1-30-8-5-19-16(13-30)9-15(10-20(19)28-17-3-4-17)21-12-26-22(25)23(29-21)32-18-11-27-31(14-18)7-2-6-24;1-3-25-19-10-15(9-16-13-29(2)8-5-18(16)19)20-12-26-21(24)22(28-20)31-17-11-27-30(14-17)7-4-6-23/h11-14,17,19,22H,3-10,15-16H2,1-2H3,(H2,28,29);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27);9-12,14,17,28H,2-5,7-8,13H2,1H3,(H2,25,26);9-12,14,25H,3-5,7-8,13H2,1-2H3,(H2,24,26)
InChIKeyLJSAGNWYVQOLBR-UHFFFAOYSA-N
XLogP13.96
TPSA406.48 Ų
H-Bond Donors6
H-Bond Acceptors34
Rotatable Bonds25
Heavy Atoms131
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001770.23
LogP ≤ 513.96
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1034

Analyze 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine?
The IUPAC name of 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine (CID 167613436) is 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine.
What is the SMILES notation for 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine?
The canonical SMILES for 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine is CCN1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.CCNc1cc(-c2cnc(N)c(Oc3cnn(CCC#N)c3)n2)cc2c1CCN(C)C2.CN1CCc2c(cc(-c3cnc(N)c(Oc4cnn(CCC#N)c4)n3)cc2NC2CC2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(CC5CC5)CC4)c3)n2)cc2c1CCN(C)C2.
What is the InChIKey of 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine?
The InChIKey is LJSAGNWYVQOLBR-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H35N7O.C25H33N7O.C23H26N8O.C22H26N8O/c1-18-11-20(12-21-16-32(2)8-7-24(18)21)25-14-29-26(28)27(31-25)35-23-13-30-34(17-23)22-5-9-33(10-6-22)15-19-3-4-19;1-4-31-9-5-20(6-10-31)32-16-21(13-28-32)33-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18;1-30-8-5-19-16(13-30)9-15(10-20(19)28-17-3-4-17)21-12-26-22(25)23(29-21)32-18-11-27-31(14-18)7-2-6-24;1-3-25-19-10-15(9-16-13-29(2)8-5-18(16)19)20-12-26-21(24)22(28-20)31-17-11-27-30(14-17)7-4-6-23/h11-14,17,19,22H,3-10,15-16H2,1-2H3,(H2,28,29);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27);9-12,14,17,28H,2-5,7-8,13H2,1H3,(H2,25,26);9-12,14,25H,3-5,7-8,13H2,1-2H3,(H2,24,26).
What are the key properties of 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine?
3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine has a molecular weight of 1770.23 g/mol, XLogP of 13.96, 25 rotatable bonds, 6 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[3-amino-6-[5-(cyclopropylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[4-[3-amino-6-[5-(ethylamino)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]pyrazin-2-yl]oxypyrazol-1-yl]propanenitrile;3-[1-[1-(cyclopropylmethyl)piperidin-4-yl]pyrazol-4-yl]oxy-5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine is sourced from PubChem (CID 167613436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).